Survival differences between chemotherapy and chemoradiotherapy in metastatic esophageal cancer: a propensity score-matched study based on the SEER database.

Shao, Yue; Zhang, Min; Ye, Liu; Chen, Dan; Wu, Qing-Chen; Zhang, Cheng

Shao, Yue; Zhang, Min; Ye, Liu; Chen, Dan; Wu, Qing-Chen; Zhang, Cheng.

Afiliación

Shao Y; Department of Cardiothoracic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Zhang M; Department of Cardiothoracic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Ye L; The First Branch, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Chen D; Department of Cardiothoracic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Wu QC; Department of Cardiothoracic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Zhang C; Department of Cardiothoracic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Ann Palliat Med ; 10(4): 3826-3835, 2021 Apr.

Article en En | MEDLINE | ID: mdl-33691433

Asunto(s)

Adenocarcinoma; Neoplasias Esofágicas; Carcinoma de Células Escamosas de Esófago; Adenocarcinoma/terapia; Quimioradioterapia; Neoplasias Esofágicas/terapia; Humanos; Pronóstico; Puntaje de Propensión

Palabras clave

Prognosis; chemoradiotherapy; chemotherapy; metastatic esophageal cancer (mEC)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Adenocarcinoma / Carcinoma de Células Escamosas de Esófago Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Ann Palliat Med Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google